NEXT Dallas — Dallas, Texas

NEXT Dallas is a clinical research site located in Dallas, Texas, United States 75231.

Crixeo Health Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.

NEXT Dallas has participated in 5 clinical trials with 5 currently active.

Therapeutic areas: Solid Tumor, Advanced Solid Tumor, Cancer.

Sponsors: Pyxis Oncology, Inc, Conjupro Biotherapeutics, Inc., SystImmune Inc..

Sponsor Feasibility Report

Trust Score: 72/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for NEXT Dallas?

NEXT Dallas has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has NEXT Dallas conducted?

NEXT Dallas has 5 clinical trials on record, with 5 currently active. Their work covers Solid Tumor, Advanced Solid Tumor, Cancer.

Is NEXT Dallas accredited by Crixeo Health?

Yes — NEXT Dallas holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about NEXT Dallas?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.